Abstract. Triple-negative breast cancer (TNBC) is a subtype of breast cancer. MicroRNA (miR)-214 is closely associated with controlling the development of tumor cells; therefore, in the present study, the target gene and effects of miR-214 on TNBC cells were explored. Luciferase activity was examined by luciferase reporter assay. The viability, invasion and migration of MDA-MB-231 TNBC cells were measured using Cell Counting kit-8, Transwell and wound-healing assays, respectively. The expression levels of various factors were determined using reverse transcription-quantitative polymerase chain reaction and western blotting. The results demonstrated that the expression levels of miR-214 were higher and the levels of α1-antitrypsin (α1-AT) were lower in TNBC tissues compared with in normal tissues. Subsequently, α1-AT was revealed to be a target of miR-214. Furthermore, inhibition of miR-214 decreased cell viability, invasion and migration, enhanced the expression of E-cadherin and tissue inhibitor of metalloproteinases-2, and reduced the expression of metastatic tumour antigen 1 and matrix metalloproteinase-2. Inhibition of miR-214 also significantly downregulated the phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR), and markedly downregulated that of phosphoinositide 3-kinase (PI3K); however, the expression levels of total PI3K, Akt and mTOR remained stable in all groups. Taken together, these findings indicated that α1-AT may be a target of miR-214. Downregulation of miR-214 markedly suppressed the viability, migration and invasion of MDA-MB-231 cells, and inhibited the PI3K/Akt/mTOR pathway. These findings suggested that miR-214 targeting α1-AT may be a potential mechanism underlying TNBC development.
Introduction
Cancer is the second most common disease that threatens human health and mortality globally (1) . Among women, breast cancer (BC) has the highest incidence of all malignant tumors (2) . Triple-negative BC (TNBC) is a subtype of BC, which accounts for 10-20% of cases of BC globally. TNBC is characterized by negative expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2, and is considered an independent clinicopathological type of cancer that is characterized by strong invasiveness (3) (4) (5) . Metastasis is a critical biological hallmark of malignant tumors and is the leading cause of mortality among patients with TNBC (6) (7) (8) ; however, the specific process and underlying mechanism remains unclear. Therefore, further study of the mechanism underlying TNBC metastasis and exploration of its effective prevention are of great significance in terms of improving the survival rate and quality of life for patients.
MicroR NAs (m i R NAs/m i Rs) a re non-coding single-stranded RNA molecules, which consist of ~22 nucleotides (9) . The role of miRNAs is fulfilled by regulating the expression of target genes, which is regulated by complementary binding of the miRNA to the 3'-untranslated region (3'UTR) of the target gene mRNA (10, 11) . miRNAs may act as oncogenes or tumor suppressor genes in the development of cancer (12) (13) (14) (15) . Numerous studies have reported that the abnormal expression of miRNAs is closely associated with the development of various tumor types (13) (14) (15) (16) (17) (18) , and miRNAs are expected to be a novel molecular target for the diagnosis and treatment of cancer. The abnormal expression of miR-214 contributes to the formation of various human tumors, including ovarian cancer, colorectal cancer, gastric cancer and BC (19) (20) (21) (22) . Furthermore, miR-214 is closely associated with regulation of the development of tumor cells, including cell growth, apoptosis and metastasis (21, (23) (24) (25) ; however, at present, the role and target of miR-214 in TNBC is not fully understood.
The phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signal (26) (27) (28) . In recent years, abnormal activation of the PI3K/Akt/mTOR pathway has been detected in numerous human malignant tumors, and activation of this pathway may be a critical factor leading to the proliferation and metastasis of tumor cells (29) (30) (31) .
In the present study, the target gene of miR-214 in TNBC was analyzed using the microRNA.org website. In addition, the effects of miR-214 on the growth and metastasis of TNBC cells, and the associated pathways were analyzed.
Materials and methods
Tissue collection. Between June 2016 and November 2017, 37 TNBC, 37 non-TNBC BC and 37 normal tissues were collected from patients with TNBC (38-55 years), patients with n-TNBC (35-53 years) and normal control individuals (all female, 36-52 years) who were diagnosed and subjected to mastectomy at the Second Affiliated Hospital of Kunming Medical University (Kunming, China). All patients provided written informed consent and allowed their tissues to be used for research purposes. The present study was approved by the Ethics Committee of the Second Affiliated Hospital of Kunming Medical University.
Cell culture. The MDA-MB-231 human TNBC cell line was purchased from Cobioer Biosciences Co., Ltd. (Nanjing, China). The cells were cultured in RPMI-1640 medium (Huayueyang Biotechnology Co., Ltd., Beijing, China) supplemented with 10% fetal bovine serum (FBS; Hangzhou Sijiqing Biological Engineering Materials Co., Ltd., Hangzhou, China), and a mixture of penicillin (100 µg/ml) and streptomycin (100 U/ml; Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) in a 95% humidified incubator (Sanyo Electric Co., Ltd.; Panasonic Corporation, Kadoma, Japan) containing 5% CO 2 at 37˚C .
Cell transfection. miR-214 mimics, miR-214 inhibitor and miRNA negative control (NC) were purchased from Vigene Biosciences (Rockville, MD, USA). The miRNA sequences were as follows: miR-214 mimics, 3'-UGA CGG ACA GAC ACG GAC GAC A-5'; miRNA inhibitor, 3'-ACU GCC UGU CUG UGC CUG CUG U-5'; and miRNA NC, 5'-UCU ACU CUU UCU AGG AGG UUG UGA-3'. Cell transfection with miR-214 mimics (100 pmol), inhibitor (100 pmol) or miRNA NC (100 pmol) was performed when the confluence of MDA-MB-231 cells reached ~60%. Transfection was conducted using Lipofectamine Luciferase reporter assay. Putative targets of miR-214 were predicted using miRanda version 3.3a (microRNA. org). Luciferase activity was determined using the Dual-Luciferase ® Reporter Assay (Promega Corporation, Madison, WI, USA). Briefly, 293 cells (Cobioer Biosciences Co., Ltd.) were co-transfected with miR-214 mimics or miRNA NC and α1-AT-3'UTR or α1-AT-3'UTR mutant (mut) plasmids (400 ng) using Lipofectamine ® 2000 at 37˚C for 24 h; a QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, Inc., Santa Clara, CA, USA) was used to obtain α1-AT-3'UTR mutant. The cells were lysed using 1X passive lysis buffer at room temperature for 15 min and the suspension was transferred to the black enzyme plate. LARII (100 µl) and Stop&Glo ® reagent (100 µl) were then added to the plates at room temperature, and luciferase activity normalized to Renilla luciferase was immediately measured using a GloMax ® Discover Multimode Microplate Reader (GM3000; Promega Corporation).
RT-qPCR analysis. Total RNA was extracted from cells and tissues using RNA extraction kit (Takara Biotechnology Co., Ltd., Dalian, China). Subsequently, 1 µg RNA was used to synthesize cDNA using the SuperScript ® VILO™ cDNA synthesis kit (Thermo Fisher Scientific, Inc.). The RT reaction conditions were as follows: 30˚C for 10 min, 42˚C for 30 min and 95˚C for 5 min. cDNA was then amplified using Fast SYBR ® Green Master Mix (Thermo Fisher Scientific, Inc.). The qPCR reaction conditions were as follows: 95˚C for 10 sec, followed by 40 cycles at 95˚C for 5 sec and 60˚C for 30 sec, and a final step at 75˚C for 1 min. Primer sequences are listed in Table I . U6 and β-actin were used as internal controls. mRNA expression levels were quantified using the 2 -ΔΔCq method (32) .
Western blot analysis. Total proteins were lysed from cells and tissues using radioimmunoprecipitation assay buffer (Beijing Solarbio Science & Technology Co., Ltd.), and protein concentrations were determined using bicinchoninic acid protein assay (Thermo Fisher Scientific, Inc.). Proteins (1 µg/µl; 10 µg/lane) were separated by 12% SDS-PAGE and were transferred onto polyvinylidene fluoride membranes (Hangzhou RENO Membrane Technology, Co., Ltd., Hangzhou, China, www.renomem.com). Subsequently, 5% non-fat milk was used to block the membranes at room temperature for 1.5 h. The membranes were then hybridized to anti-α1-AT (cat. no. 3 cells/well) at 37˚C for 24 h. Subsequently, cells were exposed to PBS (control), miRNA NC or miR-214 inhibitor at 37˚C for 6, 12 and 24 h. CCK-8 reagent (10 µl) was then added to the cells, which were incubated for a further 4 h at 37˚C. The optical density value was then assessed at 450 nm using a microplate reader (SMR16.1; Uscn Life Sciences, Inc., Wuhan, China).
Wound-healing assay. Cells were seeded in a 6-well plate (6x10 4 cells/well) and were cultured for 24 h. The cells were then exposed to PBS (control), or were transfected with miRNA NC or miR-214 inhibitor. Subsequently, the cells were scratched using a 200-µl pipette tip (Thermo Fisher Scientific, Inc.). Following culturing at 37˚C for 24 h, the cells were observed under a DSX100 optical microscope (Olympus Corporation, Tokyo, Japan).
Transwell assay. Matrigel (200 µg/ml, 100 µl; BD Biosciences, Franklin Lakes, NJ, USA) was added to the upper Transwell chamber at room temperature until it solidified, after which, cells were added to the upper chamber. The medium supplemented with 15% FBS was added to the lower chamber. The transfected cells were centrifuged at 5,000 x g for 20 min at 4˚C, and the cell suspension (2x10 5 cells/ml) was cultured in the upper chamber at 37˚C for 24 h. Crystal violet (0.1%; Shanghai Gefan Biotechnology Co., Ltd., Shanghai, China) was used to stain the cells for 20 min. Finally, cells were observed under a DSX100 optical microscope (Olympus Corporation).
Statistical analysis. All data are presented as the mean ± standard error of mean, as determined by Excel 2010 (Microsoft Corporation, Redmond, WA, USA). Data were analyzed using SPSS software (version 13.0; SPSS, Inc., Chicago, IL, USA). The differences among groups were determined by one-way analysis of variance, followed by Dunnett's test. Each experiment was performed in triplicate and repeated three times. P<0.05 was considered to indicate a statistically significant difference.
Results
Expression levels of miR-214 and α1-AT among patients with BC. RT-qPCR was used to analyze the expression levels of miR-214 and α1-AT in normal, n-TNBC and TNBC tissues. In n-TNBC and TNBC tissues, the expression levels of miR-214 were higher and the mRNA expression levels of α1-AT were lower than in normal tissue (P<0.01; Fig. 1A and 1B) . In addition, according to miRanda, α1-AT was predicted to possess an miR-214-binding site (Fig. 1C) . Subsequently, it was revealed that the luciferase activity of α1-AT-3'UTR was reduced in cells transfected with miR-214 mimics; however, miR-214 mimics did not affect the luciferase activity of α1-AT-3'UTR mut (Fig. 1D) . Furthermore, the expression levels of α1-AT were decreased following upregulation of miR-214 via transfection with miR-214 mimics (Fig. 1E-G) . These results suggested that α1-AT may be a target of miR-214. 
Suppression of miR-214 attenuates the viability of MDA-MB-231 cells.
In order to examine the effects of a miR-214 inhibitor on MDA-MB-231 cells, the expression levels of miR-214 and cell viability were detected by RT-qPCR and CCK-8 assay, respectively. The results of RT-qPCR revealed that the expression levels of miR-214 were significantly decreased in cells transfected with miR-214 inhibitor (Fig. 1H ).
In addition, the miR-214 inhibitor markedly suppressed cell viability at 12 and 24 h (Fig. 1I) .
Suppression of miR-214 reduces the migratory and invasive abilities of MDA-MB-231 cells.
Wound-healing and Transwell assays were conducted to study the effects of a miR-214 inhibitor on the migratory and invasive abilities of MDA-MB-231 cells. As the wound-healing assay results indicated, in cells transfected with a miR-214 inhibitor, the relative wound width was markedly increased (Fig. 2A) . The results of the Transwell assay indicated that the miR-214 inhibitor significantly decreased the relative invasion rate of cells (Fig. 2B) .
Suppression of miR-214 regulates migration-associated factors in MDA-MB-231 cells.
RT-qPCR and western blotting were performed to study the effects of miR-214 inhibition on the expression of migration-associated factors. As shown in Fig. 3A -D, the mRNA expression levels of E-cadherin and TIMP2 were increased, whereas the mRNA expression levels of MTA1 and MMP2 were decreased in cells transfected with a miR-214 inhibitor. In addition, alterations in the protein expression levels of E-cadherin, TIMP2, MTA1 and MMP2 were consistent with alterations in the mRNA expression levels (Fig. 3E) .
Suppression of miR-214 inhibits the PI3K/Akt/mTOR signaling pathway in MDA-MB-231 cells.
In order to investigate the effects of the miR-214 inhibitor on signaling in MDA-MB-231 cells, the PI3K/Akt/mTOR signaling pathway was examined by western blotting. The results revealed that transfection with the miR-214 inhibitor markedly downregulated phosphorylation of PI3K, Akt and mTOR. However, the expression levels of total PI3K, Akt and mTOR remained stable in the various groups (Fig. 4) . The proportions of p-Akt/Akt and p-mTOR/mTOR were significantly reduced by the miR-214 inhibitor (Fig. 4) .
Discussion
Increasing evidence has demonstrated that miR-214 is aberrantly expressed and its function is altered in various types of tumor; in particular, low miR-214 expression has been detected in liver cancer and ovarian carcinoma (21, 33) , whereas high miR-214 expression has been observed in BC, gastric cancer and pancreatic cancer (20, 24, 34) . Notably, Kalniete et al (20) detected high expression levels of miR-214 in patients with TNBC. Similar to this previous study, the present data demonstrated that miR-214 was highly expressed in TNBC tissues. α1-AT is a member of the serine protease inhibitor superfamily, which is dysregulated in lung cancer, prostate cancer and BC (35, 36) . Previous studies have reported that α1-AT may act as a tumor suppressor in BC cells (37, 38) . The present data revealed that the expression levels of α1-AT were decreased in TNBC tissues. According to microRNA. org, α1-AT was identified as a target gene of miR-214. In addition, when MDA-MB-231 cells were transfected with miR-214 mimics, the expression levels of α1-AT were downregulated. Therefore, these findings suggested that α1-AT may be a target gene of miR-214, and that miR-214 may exert its effect on TNBC through targeting α1-AT.
Cell proliferation, invasion and migration are known to be essential processes associated with tumor development. Wang et al (39) E-cadherin is an intercellular adhesion molecule, and downregulation of E-cadherin decreases intercellular adhesion (42) . The main function of MMPs is to degrade and reshape the dynamic balance of the extracellular matrix. A previous study reported that when tumor cell metastasis is inhibited, the levels of E-cadherin are upregulated and the levels of MMPs are downregulated (43) . TIMPs are tissue inhibitors of the MMP family, and MTAs are also a class of critical tumor metastasis-associated genes. It has been reported that tumor necrosis factor α suppresses radiation-induced cell metastasis in neuroblastoma via increasing TIMP2 and E-cadherin levels, and decreasing MTA-2 and MMP levels (44) . Therefore, this study examined the effects of miR-214 on the migration/invasion-associated factors using RT-qPCR and western blotting. It was revealed that miR-214 silencing decreased cell migration and invasion via upregulating E-cadherin and TIMP2, and downregulating MTA1 and MMP2.
Previous studies have demonstrated that miR-214 has a role in regulating the PI3K/Akt/mTOR pathway under various pathological conditions (25, 45, 46) . Liu et al (25) reported that miR-214 controls the PI3K/Akt pathway via targeting phosphatase and tensin homolog in oophoroma. Zhao et al (46) also indicated that miR-214 expedited osteoclastogenesis via regulating PI3K/Akt signaling. Li et al (45) demonstrated that miR-214 mediates the PI3K/Akt/mTOR signaling pathway in rat muscle atrophy. Therefore, it was hypothesized that miR-214 may mediate the PI3K/Akt/mTOR pathway in TNBC. As expected, knockdown of miR-214 suppressed the PI3K/Akt/mTOR pathway in MDA-MB-231 cells.
In conclusion, this study demonstrated that miR-214 was highly expressed in TNBC tissues, and that α1-AT was a target gene for miR-214. Silencing of miR-214 markedly suppressed the proliferation, migration/invasion of MDA-MB-231 cells by upregulating E-cadherin and TIMP2, and downregulating MTA1 and MMP2. Furthermore, miR-214 silencing inhibited the PI3K/Akt/mTOR pathway. These findings indicated that miR-214 targeting α1-AT may be a potential mechanism underlying TNBC development. 
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